Blood Cancer UK Research

Registered charity 216032 · accounts filings on the Charity Commission register · also known as BLOODWISE, Blood Cancer UK, LEUKAEMIA & LYMPHOMA RESEARCH, LEUKAEMIA RESEARCH, LEUKAEMIA RESEARCH FUND · also registered in Scotland as SC037529 (OSCR)

Latest income
£21.1m
Latest spending
£20.2m
Registered
1962
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that total income reached £21.1 million, a 14% increase from the previous year, driven by strong legacy and fundraising performance. Total expenditure rose to £20.2 million, resulting in a net deficit of £0.1 million after investment losses, with free reserves held at £4.5 million, which is within the stated policy target range of £3.8 million to £7.5 million.

What the accounts disclose

Related-party transaction: Donations received from Trustees.
Total donations received without conditions from Trustees during the year were £67,306 (2023/24: £24,072).
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Crowe U.K. LLP.

Corporate structure

Public fundraising profile: JustGiving — Blood Cancer UK (matched by registered charity number).

Structured financials (annual return, FY ending 31/03/2025)

Total income
£21.1m
Total spending
£20.2m
Cost of raising funds
£6.6m
Reserves (reported)
£4.5m
Employees
131

Reported reserves equal ~2.7 months of spending — below the median for charities its size (median 4.6 months; benchmarks).

Register events

Trustees

Trustee list from the Charity Commission register (current, not historical).

Operates in: Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025£21.1m£20.2m
31/03/2024£18.5m£16.8m
31/03/2023£18.7m£14.4m
31/03/2022£13.3m£13.5m
31/03/2021£12.5m£9.3m

Common questions

Is Blood Cancer UK Research financially healthy?

The accounts state that total income reached £21.1 million, a 14% increase from the previous year, driven by strong legacy and fundraising performance. Total expenditure rose to £20.2 million, resulting in a net deficit of £0.1 million after investment losses, with free reserves held at £4.5 million, which is within the stated policy target range of £3.8 million to £7.5 million. Its FY2025 accounts were audited by Crowe U.K. LLP.

Who funds Blood Cancer UK Research?

Funders whose own accounts filings name Blood Cancer UK Research as a grant recipient include THE FRANCES AND AUGUSTUS NEWMAN FOUNDATION, DAVID & RUTH LEWIS FAMILY CHARITABLE TRUST, OGLESBY CHARITABLE TRUST, THE EMMANUEL KAYE FOUNDATION, THE GEORGE GOODSIR CHARITABLE TRUST.

Known funders

Grants to this charity found in funders’ own accounts filings.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with BLOOD CANCER ALLIANCE.